A Clinical Study of PD-L1 Antibody ZKAB001（Drug Code） in Recurrent or Metastatic Cervical Cancer

NCT03676959 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

101

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: ZKAB001 5mg/kg
DRUG: ZKAB001 10mg/kg
DRUG: ZKAB001 15mg/kg

Sponsor

Lee's Pharmaceutical Limited